Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome

NCT04279314 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
154
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ACADIA Pharmaceuticals Inc.